Literature DB >> 115895

New serotypes of group B streptococci isolated from human sources.

B Perch, E Kjems.   

Abstract

Antisera raised in rabbits against two nontypable group B streptococci, which were not agglutinable in a specific group B antiserum, were tested with acid extracts of 78 nontypable human group B streptococci. One antiserum (12351) reacted with 15 strains, and the other (7271) reacted with only 2 strains. Antiserum to Wilkinson's strain SS 1169 (NT 1) reacted with three strains. Antiserum against strain 12351 appears to be a useful antiserum against a new type antigen, which is probably polysaccharide in nature.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 115895      PMCID： PMC273104          DOI： 10.1128/jcm.10.1.109-110.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

Review 1.  Group B streptococcal infection in humans.

Authors:  H W Wilkinson
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

Review 2.  Group B streptococci in the human population.

Authors:  J Jelínkoá
Journal:  Curr Top Microbiol Immunol       Date:  1977       Impact factor: 4.291

3.  Group B streptococcal neonatal and infant infections.

Authors:  R A Franciosi; J D Knostman; R A Zimmerman
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

4.  Nontypable group B streptococci isolated from human sources.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1977-08       Impact factor: 5.948

5.  Epidemiology of group-B streptococcal carriage in pregnant women and newborn infants.

Authors:  P Ferrieri; P P Cleary; A E Seeds
Journal:  J Med Microbiol       Date:  1977-02       Impact factor: 2.472

6.  Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis).

Authors:  H W Wilkinson; R R Facklam; E C Wortham
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

7.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307
  7 in total
  16 in total

1.  False-negative results in typing of group B streptococci by the standard lancefield antigen extraction method.

Authors:  H-C Slotved; S Sauer; H B Konradsen
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  Identification of Group B Streptococcus Capsule Type by Use of a Dual Phenotypic/Genotypic Assay.

Authors:  Areej Alhhazmi; Armaan Pandey; Gregory J Tyrrell
Journal:  J Clin Microbiol       Date:  2017-06-14       Impact factor: 5.948

3.  Genetic diversity of rRNA operons of unrelated Streptococcus agalactiae strains isolated from cerebrospinal fluid of neonates suffering from meningitis.

Authors:  S Chatellier; H Huet; S Kenzi; A Rosenau; P Geslin; R Quentin
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

4.  Streptococcal group B type antigen X in group L streptococci.

Authors:  C Lämmler; K Gürtürk; H Blobel
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

5.  Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes.

Authors:  D R Johnson; P Ferrieri
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

6.  Worldwide distribution of two new serotypes of group B streptococci: type IV and provisional type V.

Authors:  J Jelínková; J Motlová
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

7.  The use of FA-technique for detecting Francisella tularensis in formalin fixed material. A method useful in routine post mortem work.

Authors:  T Mörner
Journal:  Acta Vet Scand       Date:  1981       Impact factor: 1.695

8.  Serotypes of group B streptococci and their relation to hyaluronidase production and hydrolysis of salicin.

Authors:  E Kjems; B Perch; J Henrichsen
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

9.  Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).

Authors:  C von Hunolstein; S D'Ascenzi; B Wagner; J Jelínková; G Alfarone; S Recchia; M Wagner; G Orefici
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

10.  Complement and antibody participation in opsonophagocytosis of type IV and V group B streptococci.

Authors:  M A Hall; M S Edwards; C J Baker
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.